Treatment Intensification With Either Fludarabine, AraC, G-CSF and Idarubicin, or Cladribine Plus Daunorubicin and AraC on the Basis of Residual Disease Status in Older Patients With AML: Results From ...
GNAS mutations at locus 201 were found in 66% of intraductal papillary mucinous neoplasms. Investigators claim mutations in a gene known as GNAS can help distinguish between nonmalignant pancreatic ...
Breast Cancer Screening Interval: Effect on Rate of Late-Stage Disease at Diagnosis and Overall Survival The ideas and opinions expressed in this Data Supplement do not necessarily reflect those of ...
Only about 11% of people will survive five years after the detection of advanced pancreatic cancer. Such a low rate of success in treating pancreatic cancer is due to its late detection and an ...
This study showed that some variants in GNAS (encoding the Gα s protein) cause childhood obesity. Subsequent findings indicate the broad clinical variability of a monogenic disease and have ...
GNAS mutations underlie pseudohypoparathyroidism. GNAS sequencing is usually performed only when clinical features of pseudohypoparathyroidism are evident, so the true prevalence of pathologic GNAS ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results